Simensen, Randi http://orcid.org/0000-0001-5291-9375
Fjose, Lars Olav
Rehn, Marius http://orcid.org/0000-0001-9519-241X
Hagemo, Jostein http://orcid.org/0000-0003-4420-5588
Thorsen, Kjetil
Heyerdahl, Fridtjof http://orcid.org/0000-0001-9602-4370
Funding for this research was provided by:
Stiftelsen Norsk Luftambulanse
University of Oslo
Article History
Received: 31 March 2023
Accepted: 16 August 2023
First Online: 5 September 2023
Declarations
:
: This trial is approved by the Regional Committee for Medical and Health Research Ethics (REC) in Norway (ref. 255159), registered ClinicalTrials.gov (ref. NCT05137184) 30 November 2021 (ExternalRef removed) and EudraCT (ref. 2021–000549-42). Important protocol modifications are communicated to REC, the Norwegian Medicinal Agency, which updates EudraCT, and to Clinical Trials.gov. The study will be performed in accordance with the Helsinki declaration. The study is based on the patients’ oral consent, witnessed and confirmed with the EMS provider’s signature in an informed consent form (ICF). For eligible patients, the EMS provider on-site reads out a predefined text to explain the nature of the study. Patients included in the study receive written study information including detailed information on how to withdraw from the study.
: The participants oral consent includes publishing approval, and the written participant information brochure contains publication-related information.
: The authors declare no competing interests.